Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 4 (2007), Issue 7 (July)

1. Synergistic antitumor effects of celecoxib with 5-fluorouracil depend on IFN-gamma.
   Int J Cancer, 121(4): 878-83. [Abstract] [Full-text]
2. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials.
   J Natl Cancer Inst, 99(13): 998-1003. [Abstract] [Full-text]
3. The impact of technical factors on outcome of restorative proctocolectomy for familial adenomatous polyposis.
   Dis Colon Rectum, 50(7): 952-61. [Abstract] [Full-text]
4. Endobronchial metastases from colon cancer without liver metastases: report of eight cases.
   Dis Colon Rectum, 50(7): 1087-9. [Abstract] [Full-text]
5. Lysophosphatidic acid prevents apoptosis of Caco-2 colon cancer cells via activation of mitogen-activated protein kinase and phosphorylation of Bad.
   Biochim Biophys Acta, 1770(8): 1194-203. [Abstract] [Full-text]
6. Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer.
   Biochem Biophys Res Commun, 360(2): 394-400. [Abstract] [Full-text]
7. Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases.
   Arch Surg, 142(7): 675-82. [Abstract] [Full-text]
8. The significance of inadvertent splenectomy during colorectal cancer resection.
   Arch Surg, 142(7): 668-74. [Abstract] [Full-text]
9. Randomized, multicenter trial of antibiotic prophylaxis in elective colorectal surgery: single dose vs 3 doses of a second-generation cephalosporin without metronidazole and oral antibiotics.
   Arch Surg, 142(7): 657-61. [Abstract] [Full-text]
10. Stents for palliation of obstructive metastatic colon cancer: impact on management and chemotherapy administration.
    Arch Surg, 142(7): 619-23; discussion 623. [Abstract] [Full-text]
11. Tamoxifen forms DNA adducts in human colon after administration of a single [14C]-labeled therapeutic dose.
    Cancer Res, 67(14): 6995-7002. [Abstract] [Full-text]
12. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.
    Cancer Res, 67(14): 6844-53. [Abstract] [Full-text]
13. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
    J Natl Cancer Inst, 99(14): 1120-9. [Abstract] [Full-text]
14. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
    Oncogene, 26(33): 4833-41. [Abstract] [Full-text]
15. Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture.
    J Pineal Res, 43(2): 195-205. [Abstract] [Full-text]
16. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.
    Mol Pharmacol, 72(2): 395-406. [Abstract] [Full-text]
17. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells.
    J Cell Physiol, 213(1): 65-9. [Abstract] [Full-text]
18. Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU.
    Cancer Immunol Immunother, 56(10): 1605-13. [Abstract] [Full-text]
19. Abnormal expression of M1/MUC5AC mucin in distal colon of patients with diverticulitis, ulcerative colitis and cancer.
    Int J Cancer, 121(7): 1543-9. [Abstract] [Full-text]
20. Mutations of the PIK3CA gene in hereditary colorectal cancers.
    Int J Cancer, 121(7): 1627-30. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.